Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02864108 · ClinicalTrials.gov registry record

The Human Trisome Project

A clinical trial of Down Syndrome and Trisomy 21, sponsored by University of Colorado, Denver.

Recruiting
Registry status
2,500
Enrollment target
1
Study location

NCT02864108 is a study of Down Syndrome and Trisomy 21 that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 2,500 participants, roughly in line with the 2,425-participant average among 54 other Down Syndrome trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02864108, a study of Down Syndrome and Trisomy 21, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
2,500 participants
Enrollment target
1
Study location

Study Summary

The Human Trisome Project will significantly increase the speed of Down syndrome research and the understanding of associated medical conditions. Its biobank will provide de-identified samples to research.

Conditions Studied

Study Locations (1)

Colorado

  • Linda Crnic Institute for Down Syndrome at the University of Colorado Denver - Denver

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2016-07
Est. Completion 2036-07

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02864108

The ClinicalTrials.gov registry entry for NCT02864108 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,425-participant average among 54 other Down Syndrome trials with a reported enrollment target. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Down Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT02864108 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02864108 about?

NCT02864108 is a clinical study titled "The Human Trisome Project". The Human Trisome Project will significantly increase the speed of Down syndrome research and the understanding of associated medical conditions. Its biobank will provide de-identified samples to research.

What is the current status of trial NCT02864108?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2016-07. Estimated completion is 2036-07.

What conditions does trial NCT02864108 study?

This clinical trial studies the following conditions: Down Syndrome, Trisomy 21.

Who is sponsoring clinical trial NCT02864108?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02864108 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.